Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.07% | 16.24% | 3.54% | 6.50% | -51.18% |
| Total Depreciation and Amortization | -3.51% | 1.48% | 5.35% | -12.15% | 12.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.61% | -24.02% | -10.88% | -52.53% | 195.09% |
| Change in Net Operating Assets | -15.70% | -459.82% | 85.21% | -1,903.40% | 102.92% |
| Cash from Operations | -18.52% | 2.61% | 18.91% | -20.33% | 14.73% |
| Capital Expenditure | -61.80% | -- | -- | -6,534.62% | 104.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -61.80% | -- | -- | -6,534.62% | 104.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 405.98% | 1,435.06% | 701.89% | -99.96% | 884.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | 200.00% |
| Cash from Financing | 425.82% | 1,386.35% | 701.89% | -99.95% | 184.43% |
| Foreign Exchange rate Adjustments | 128.92% | -250.50% | 138.89% | 127.10% | -164.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.33% | 24.52% | 25.17% | -137.37% | 787.68% |